Image cytometry of early nuclear events during apoptosis induced by camptothecin in HL-60 leukemic cells

Cytometry

Volumn 25, Issue 4, 1996, Pages 341-348

  Palissot, Valérie ^a   Liautaud Roger, Françoise ^b   Carpentier, Yves ^b   Dufer, Jean ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b INSTITUT JEAN GODINOT   (France)

Author keywords

Apoptosis; Camptothecin; HL 60 cells; Image cytometry

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CAMPTOTHECIN; CYTOCHALASIN B; DNA FRAGMENT; STAUROSPORINE; TOSYLLYSYL CHLOROMETHYL KETONE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMETRY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LEUKEMIA CELL; PRIORITY JOURNAL;

APOPTOSIS; CAMPTOTHECIN; CELL DIVISION; CELL NUCLEUS; DNA FRAGMENTATION; DNA TOPOISOMERASES, TYPE I; HL-60 CELLS; HUMANS; IMAGE CYTOMETRY; MULTIVARIATE ANALYSIS;

EID: 0029964991     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19961201)25:4<341::AID-CYTO5>3.0.CO;2-G     Document Type: Article

References (40)

1. Aaronson RP, Woo E: Organization in the cell nucleus: Divalent cations modulate the distribution of condensed and diffuse chromatin. J Cell Biol 90:181-186, 1981.
2. Arends MJ, Morris RG, Wyllie AH: Apoptosis: The role of the endonuclease. AmJ Pathol 136:593-608, 1990.
3. Bertrand R, Solary E, Jenkins J, Pommier Y: Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp Cell Res 207:388-397, 1993
4. Brüne B, Hartzell P, Nicotera P, Orrenius S: Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp Cell Res 195:323-329, 1991.
5. Bruno S, Del Bino G, Lassota P, Giaretti W, Darzynkiewicz Z: Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes. Leukemia 6:1113-1120, 1992.
6. Collins RJ, Harmon BV, Gobe GC, Kerr JFR: Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61:451-453, 1992.
7. Cotter TG, Lennon SV, Glynn JM, Green DR: Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res 52:997-1005, 1992.
8. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Traganos F: Features of apoptotic cells measured by flow cytometry. Cytometry 13:795-808, 1992.
9. Del Bino G, Darzynkiewicz Z: Camptothecin, Teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Cancer Res 51:1165-1169, 1991.
10. Del Bino G, Skierski JC, Darzynkiewicz Z: The concentration dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195:485-491, 1991.
11. Dufer J, Millot-Broglio C, Oum'Hamed Z, Liautaud-Roger F, Joly P, Desplaces A, Jardillier JC: Nuclear DNA and chromatin texture in multidrug-resistant human leukemic cell lines. Int J Cancer 60:108-114, 1995.
12. Elstein KH, Thomas DJ, Zucker RM: Factors affecting flow cytometric detection of apoptotic nuclei by DNA analysis. Cytometry 21: 170-176, 1995.
13. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992.
14. Ferlini C, Di Cesare S, Rainaldi G, Malorni W, Samoggia P, Biselli R, Fattorossi A: Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 24:106-115, 1996.
15. Galloway MM: Texture analysis using gray-level run lengths. Comp Graph Image Proc 4:172-179, 1975.
16. Giroud F: Approches cytometriques de la proliferation et de la differenciation: notion de facies chromatinien. Ph.D thesis, University of Grenoble, Grenoble, 1987.
17. Giroud F, Gauvain C, Seigneurin D, Von-Hagen V: Chromatin texture changes related to proliferation and maturation in erythrocytes. Cytometry 9:339-348, 1988.
18. Giroud F, Montmasson MP: Reevaluation of optimal Feulgen reaction for automated cytology. Influence of fixatives. Anal Quant Cytol Histol 11:87-95, 1988.
19. Haralick RM, Shanmugan K, Dinstein I: Textural features for image classification. IEEE Trans Syst Man Cyber SMC 3:610-621, 1973.
20. Hotz MA, Gong J, Traganos F, Darzynkiewicz Z: Flow cytometric detection of apoptosis: Comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry 15:237-244, 1994.
21. Jarvis WD, Turner AJ, Povirk LF, Traylor RS, Grant S: Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res 54:1707-1714, 1994.
22. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide range implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
23. Kerr JFR: Neglected opportunities in apoptosis research. Trends Cell Biol 5:55-57, 1995.
24. Kiss R, Salmon I, Camby I, Gras S, Pasteels JL: Characterization of factors in routine laboratory protocols that significantly influence the Feulgen reaction. J Histochem Cytochem 41:935-945, 1993
25. Kolber MA, Broschat KO, Landa-Gonzales B: Cytochalasin B induces cellular DNA fragmentation. FASEB J 4:3021-3027, 1990.
26. Nigg EA: Targets of cyclin-dependent protein kinases. Curr Opin Cell Biol 5:187-193, 1993
27. Oberhammer F, Fritsch G, Schmied M, Pavelka M, Printz D, Purchio T, Lassmann H, Schulte-Hermann R. Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease. J Cell Sci 104:317-326, 1993.
28. Pommier Y, Tanizawa A: Mammalian DNA topoisomerase I and its inhibitors. In: Cancer Chemotherapy, Hickman J, Tritton T (eds). Blackwell Scientific Publications, Oxford, 1993, pp 214-250.
29. Schroter M, Peitsch MC, Tschopp J: Increased p34(cdc2)-dependent kinase activity during apoptosis: A possible activation mechanism of DNase I leading to DNA breakdown. Eur J Cell Biol 69:143-150, 1996.
30. Schulte EKW: Standardization of the Feulgen reaction for absorption DNA image cytometry: A review. Anal Cell Pathol 3:167-182, 1991.
31. Shimizu T, O'Connor PM, Kohn KW, Pommier Y: Unscheduled activation of cyclin B1/Cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res 55:228-231, 1995.
32. Snyder RD: Polyamine depletion is associated with altered chromatin structure in HeLa cells. Biochem J 260:697-704, 1989.
33. Sun XM, Snowden RT, Dinsdale D, Ormerod MG, Cohen GM: Changes in nuclear chromatin precede internucleosomal cleavage in the induction of apoptosis by etoposide. Biochem Pharmacol 47: 187-195, 1994.
34. Vanderbilt JN, Bloom KS, Anderson JN: Endogenous nuclease. J Biol Chem 257:13009-13017, 1982.
35. Weaver VM, Carson CE, Walker PR, Chaly N, Lach B, Raymond Y, Brown DL, Sikorska M: Degradation of nuclear matrix and DNA cleavage in apoptotic thymocytes. J Cell Sci 109:45-56, 1996.
36. Wolf D, Rotter V: Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc Natl Acad Sci USA 82:790-794, 1985.
37. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 284:555-556, 1980.
38. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: An overview. Cancer Metast Rev 11:95-103, 1992.
39. Zamai L, Falcieri E, Marhefka G, Vitale M: Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry 23:303-311, 1996.
40. Zhu WH, Loh TT: Differential effects of phorbol ester on apoptosis in HL60 promyelocytic leukemia cells. Biochem Pharmacol 51:1229-1236, 1996.